HOME ZACKS RESEARCH FUNDS PORTFOLIO BROKER RESEARCH MARKETS SCREENING EDUCATION SERVICES
Zacks Rank    Equity Research    Premium Home    My Account    Help    


Losing Stock Guy: Why He Went Wrong

By Kevin Matras
Quote:
Login Free Membership
Search:

 
Analyst Blog  

OSI Pharma's Recent Data Mixed

December 16, 2008 | Comments: 0
Recommended this article (1)
Print    Share

OSI Pharmaceuticals, Inc. (OSIP - Analyst Report), is a biotechnology company engaged in the discovery, development and commercialization of pharmaceutical products for the treatment of oncology, diabetes, and obesity in the U.S.

Tarceva sales continued to grow in both US and rest of the world in 3Q08 but at a declining rate. We believe Tarceva will achieve blockbuster status with over $1 billion in sales in 2008. We remain excited about the revenue from the company's DPP-IV estate. Additionally, the company's pipeline targets diseases like diabetes, obesity and cancer -- the very specific areas where OSI's strengths lie.

We are happy to hear about the positive data from SATURN trial, but disappointed with the negative data from the BETA trial. We maintain our Hold rating for OSIP with a price target of $36.

Read the full analyst report on OSIP



Email

Print

Share

RSS

Rate Pos

Rate Neg

Comment
Read/Post Comments (0) | Recommended this article (1)
 Posting Comment...
There was a problem posting this this comment. Please try back later.
[CLICK TO CLOSE X]
Comments (Limit 1000 Characters - Used: 0)
Display Name: Email Address:  
 Loading Comments...
Be the first to comment on this article!
Best Stocks. Best Insight. Join Now...it's FREE!
Over 550,000 investors look forward to the timely insights in our email newsletter; Zacks Profit from the Pros. In each daily issue you will find:
  • Free  Four Zacks #1 Rank "Strong Buy" Stocks
  • Free  Timely Market Commentary
  • Free  Wealth Management Tips
  • Free  Profitable Strategy Screens
  • Free  Bull and Bear Stocks of the Day
Zacks FREE Registration

More Zacks Resources

Market Summary Nov 26, 2009 08:05 am ET
DJIA 10464.4  30.69 0.29%
NASD 2176.05  6.87 0.32%
S&P 500 1110.63  4.98 0.45%
Sponsored Links